参考文献/References:
[1] Bares R,K 1 ever P, Hauptmann S, et al.F-18 fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer[J].Radiology, 1994, 192(1):79-86.
[2] Stollfuss JC, Glatting G, Friess H, et al.2-(fluorine-18)-fluoro-2-deoxy-D-glucose PET in detection of pancreatic cancer:value of quantitative image interpretation[J].Radiology, 1995, 195(2):339-344.
[3] Inokuma T, Tamaki N, Torizuka T, et al.Evaluation of pancreatic tumors with positron emission tomography and F-18 fluorodeoxyglucose:comparison with CT and U S[J].Radiology, 1995, 195(2):345-352.
[4] Friess H, Langhans J, Ebert M, et al.Diagnosis ofpancreatic cancer by 2 18F-fluoro-2-deoxy-D-glucosepositron emission tomography[J].Gut, 1995, 36(5):771-777.
[5] Zimny M,Bares R, Fass J, et al.Fluorine-18fluorodeoxyglucose positron emission tomography inthe defferential diagnosis of pancreatic carcinoma:areport of 106 cases[J].Eur J Nucl Med, 1997, 24(6):678-682.
[6] Keogan MT, Tyler D, Clark L, et al.Diagnosis ofpancreatic carcinoma:ro 1 e of FDG PET[J].Am J Roentgenol, 1998, 171(6):1565-1570.
[7] Diederichs CG, Staib L, Glatting G, et al.FDG PET:elevated plasma reduces both uptake and dection rateof pancreatic malignancies[J].J Nucl Med, 1998, 39:1030-1033.
[8] ShrevePD.Gross MD.Focal fluorine-18 fluorodeoxyglucose accumulation in inflammatory pancreatic disease[J].Eur J Nucl Med, 1998, 25:259-264.
[9] Higashi T, Tamaki N, Honda T, et al.Expression of glucose transporters in human pancreatic tumors compared with increased FDG accumulation in PET study[J], J Nucl Med, 1997, 38:1337-1344.
[10] Higashi T, Tamaki N, Honda T, et al.FDG uptake,GLU T-1 glucose transporter and cellularity in human pancreatic tumors[J].J Nucl Med, 1998, 39:1727-1735.
[11] Franke C, Klapdor R, Meyerhoff K, et al.18-FDG postrion emission tomography of the pancreas:diagnostic benefit in the following up of pancreatic carcinoma[J].Anticancer Res, 1999, 19:2437-2442.
[12] Kato T, Fukatsu H, Ito K, et al.Fluorodeoxyglucose positron emission tomography in pancreatic cancer:an unsolved problem[J].Eur J Nucl Med, 1995, 22:32-39.
相似文献/References:
[1]徐蓉生,梅艳,赵力威,等.B超引导下术中125I粒子植入治疗晚期胰腺癌的疗效评价[J].国际放射医学核医学杂志,2016,40(6):424.[doi:10.3760/cma.j.issn.1673-4114.2016.06.005]
Xu Rongsheng,Mei Yan,Zhao Liwei,et al.Evaluation of 125I particle implantation in the treatment of patients with advanced pancreatic neoplasms using B ultrasound-guided surgery[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):424.[doi:10.3760/cma.j.issn.1673-4114.2016.06.005]
[2]李詝,朱朝晖,李方.蛋白激酶小分子抑制剂PET显像研究进展及其在胰腺癌诊断中的应用前景[J].国际放射医学核医学杂志,2015,39(1):45.[doi:10.3760/cma.j.issn.1673-4114.2015.01.010]
Li Zhu,Zhu Zhaohui,Li Fang.Advances of small-molecule protein kinase inhibitor-based PET tracers with prospective application in pancreatic cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):45.[doi:10.3760/cma.j.issn.1673-4114.2015.01.010]
[3]周惠君,董萍,沈国华,等.11C-蛋氨酸PET/CT显像在脑胶质瘤中的应用价值[J].国际放射医学核医学杂志,2015,39(2):161.[doi:10.3760/cma.j.issn.1673-4114.2015.02.013]
Zhou Huijun,Dong Ping,Shen Guohua,et al.Value of 11C-methionine PET/CT imaging indiagnosing cerebral glioma[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):161.[doi:10.3760/cma.j.issn.1673-4114.2015.02.013]
[4]吴冰,石洪成.18F-FDG PET-CT在胰腺癌诊治中的应用[J].国际放射医学核医学杂志,2011,35(4):234.[doi:10.3760/cma.j.issn.1673-4114.2011.04.010]
WU Bing,SHI Hong-cheng.18F-FDG PET-CT for the clinical application of pancreatic cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(6):234.[doi:10.3760/cma.j.issn.1673-4114.2011.04.010]
[5]李亚军,白人驹,高硕,等.兔VX2肺肿瘤PET-CT与血管生成的相关性研究[J].国际放射医学核医学杂志,2010,34(3):139.
LI Ya-jun,BAI Ren-ju,GAO Shuo,et al.The correlation between PET-CT imaging and microvessed density in rabbit lung VX2 tumor model[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(6):139.
[6]邓胜明,张玮,章斌,等.188Re-胰岛素样生长因子1类似物在荷人胰腺癌裸鼠体内分布及其显像研究[J].国际放射医学核医学杂志,2008,32(3):129.
DENG Sheng-ming,ZHANG Wei,ZHANG Bin,et al.Studies on biodistribution and imaging of 188Re labeled insulin-like growth factor-1 analogue in nude mice bearing human pancreatic carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(6):129.
[7]尤徐阳,万卫星.放射免疫显像及其在胰腺癌研究中的应用[J].国际放射医学核医学杂志,2008,32(5):264.
YOU Xu-yang,WAN Wei-xing.Radioimmunoimaging progress and its value of pancreatic cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(6):264.
[8]姜炜,郭阳,徐玲,等.立体定向放射治疗胰腺癌[J].国际放射医学核医学杂志,2007,31(1):55.
JIANG Wei,GUO Yang,XU Ling,et al.Stereotactic radiotherapy for pancreatic cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2007,31(6):55.
[9]刘军叶,郭鹞,郭国祯.乏氧靶向性自杀基因治疗系统增强胰腺癌放疗效果的实验研究[J].国际放射医学核医学杂志,2006,30(3):168.
LIU Jun-ye,GUO Yao,GUO Guo-zhen.Hypoxia-targeted suicidal gene therapy system enhances antitumor effects of radiotherapy on pancreatic cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(6):168.
[10]王济东,王俊杰.胰腺癌组织间近距离放射治疗的研究进展[J].国际放射医学核医学杂志,2006,30(3):182.
WANG Ji-dong,WANG Jun-jie.Evolution of interstitial brachytherapy for pancreatic cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(6):182.